Jul 21, 2026 04:05PM
Jul 16, 2026 08:00AM
Jul 13, 2026 08:03AM
Jul 13, 2026 08:00AM
Jul 6, 2026 04:05PM
Jun 22, 2026 04:05PM
Jun 4, 2026 04:05PM Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Jun 3, 2026 08:00AM
May 27, 2026 08:00AM
May 21, 2026 04:05PM
May 20, 2026 08:01AM
May 20, 2026 08:00AM
May 7, 2026 04:05PM
May 6, 2026 07:00AM Madrigal Pharmaceuticals Reports First-Quarter 2026 Financial Results and Provides Corporate Updates
May 5, 2026 08:01AM
May 5, 2026 08:00AM
Apr 22, 2026 08:00AM
Apr 21, 2026 04:05PM
Apr 7, 2026 04:05PM
Mar 19, 2026 04:05PM
Mar 5, 2026 04:05PM Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Feb 24, 2026 08:00AM
Feb 19, 2026 07:00AM
Feb 17, 2026 04:05PM
Feb 11, 2026 06:25AM
Feb 11, 2026 05:01AM
Feb 11, 2026 05:00AM
Feb 5, 2026 04:05PM Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Feb 2, 2026 08:05AM
Jan 22, 2026 04:05PM
Jan 21, 2026 04:05PM
Jan 12, 2026 09:32AM
Jan 9, 2026 08:00AM
Jan 9, 2026 08:00AM
Dec 18, 2025 04:05PM Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Dec 15, 2025 04:05PM
Dec 4, 2025 04:05PM
Nov 20, 2025 04:05PM
Nov 20, 2025 04:02AM
Nov 17, 2025 08:00AM
Nov 10, 2025 08:02AM
Nov 10, 2025 08:00AM Madrigal Presents New Data Demonstrating Rezdiffra® (resmetirom) Significantly Improved Multiple Noninvasive Imaging Tests and Biomarkers in Patients with Compensated MASH Cirrhosis
Nov 6, 2025 04:05PM
Nov 4, 2025 07:00AM
Oct 28, 2025 08:00AM
Oct 22, 2025 08:00AM
Oct 21, 2025 04:05PM
Oct 7, 2025 04:05PM
Sep 18, 2025 04:05PM Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Sep 4, 2025 04:05PM

326,122 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All